ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

An Evaluation of the Spectra Optia CMNC Collection Procedure

ClinicalTrials.gov ID: NCT02253160

Public ClinicalTrials.gov record NCT02253160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Crossover Trial to Characterize the Performance of the Spectra Optia Apheresis System Versus the COBE Spectra Apheresis System for Collection of Mononuclear Cells in Healthy Adult Donors

Study identification

NCT ID: NCT02253160
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Terumo BCT; Industry
Enrollment: 23 participants

Conditions and interventions

Conditions

Interventions

Spectra Optia CMNC Device
COBE Spectra MNC Device
Granulocyte-colony stimulating factor (G-CSF) Drug

Device · Drug

Eligibility (public fields only)

Age range: 18 Years to 50 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2014
Primary completion: Dec 31, 2014
Completion: Dec 31, 2014
Last update posted: Sep 23, 2015

2014 – 2015

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Hoxworth Blood Center	Cincinnati	Ohio	45267-0055	—
Key Biologics, LLC	Memphis	Tennessee	38104	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02253160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 23, 2015 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02253160 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →